Uraemic pruritus - new perspectives and insights from recent trials

被引：125

作者：

Mettang, T

Pauli-Magnus, C

Alscher, DM

机构：

[1] Robert Bosch Krankenhaus, Dept Internal Med, Div Gen Internal Med & Nephrol, D-70376 Stuttgart, Germany

[2] Univ Zurich Hosp, Dept Med, Div Clin Pharmacol, CH-8091 Zurich, Switzerland

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2002年 / 17卷 / 09期

关键词：

end-stage renal disease; therapy; trials; uraemic pruritus;

D O I：

10.1093/ndt/17.9.1558

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 [基础医学]; 1002 [临床医学]; 100602 [中西医结合临床];

摘要：

[No abstract available]

引用

页码：1558 / 1563

页数：6

共 40 条

[1]

ALTMEYER P, 1986, HAUTARZT, V37, P217

[2]

ANDERSEN LW, 1984, CLIN NEPHROL, V21, P355

[3]

BALASKAS EV, 1992, PERITON DIALYSIS INT, V12, P330

[4]

BERGASA NV, 1994, J HEPATOL, V20, P85

[5]

CENTRAL MU-OPIOID RECEPTORS ARE DOWN-REGULATED IN A RAT MODEL OF CHOLESTASIS [J].

BERGASA, NV ;

ROTHMAN, RB ;

VERGALLA, J ;

XU, H ;

SWAIN, MG ;

JONES, EA .

JOURNAL OF HEPATOLOGY, 1992, 15 (1-2) :220-224

[6]

THE PRURITUS OF CHOLESTASIS - POTENTIAL PATHOGENIC AND THERAPEUTIC IMPLICATIONS OF OPIOIDS [J].

BERGASA, NV ;

JONES, EA .

GASTROENTEROLOGY, 1995, 108 (05) :1582-1588

[7]

EFFECTS OF NALOXONE INFUSIONS IN PATIENTS WITH THE PRURITUS OF CHOLESTASIS - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL [J].

BERGASA, NV ;

ALLING, DW ;

TALBOT, TL ;

SWAIN, MG ;

YURDAYDIN, C ;

TURNER, ML ;

SCHMITT, JM ;

WALKER, EC ;

JONES, EA .

ANNALS OF INTERNAL MEDICINE, 1995, 123 (03) :161-167

[8]

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis [J].

Bergasa, NV ;

Schmitt, JM ;

Talbot, TL ;

Alling, DW ;

Swain, MG ;

Turner, ML ;

Jenkins, JB ;

Jones, EA .

HEPATOLOGY, 1998, 27 (03) :679-684

[9]

UREMIC PRURITUS - SKIN DIVALENT ION CONTENT AND RESPONSE TO ULTRAVIOLET PHOTOTHERAPY [J].

BLACHLEY, JD ;

BLANKENSHIP, DM ;

MENTER, A ;

PARKER, TF ;

KNOCHEL, JP .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1985, 5 (05) :237-241

[10]

PHASE-I TRIAL OF COMBINED RECOMBINANT INTERLEUKIN-2 WITH LEVAMISOLE IN PATIENTS WITH ADVANCED MALIGNANT DISEASE [J].

CALL, TG ;

CREAGAN, ET ;

FRYTAK, S ;

BUCKNER, JC ;

VANHAELSTPISANI, C ;

HOMBURGER, HA ;

KATZMANN, JA .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (04) :344-347

← 1 2 3 4 →